facebook

Why Do Hyperopic Laser Treatments Regress More Frequently?

1 min read

Hyperopic laser ablation steepens the central cornea by removing tissue in the mid-periphery. This altered stromal geometry stimulates epithelial redistribution.

High-resolution epithelial mapping studies have demonstrated that central epithelial thickening commonly occurs following hyperopic LASIK¹. This remodelling effect reduces the achieved hyperopic correction over time.

In contrast, myopic ablations flatten the centre and often demonstrate different epithelial compensation patterns.

Clinical outcome studies have consistently shown higher regression rates in hyperopic LASIK compared to myopic LASIK². This biological tendency explains why hyperopic retreatment rates are typically greater and long-term stability may be less predictable.

The mechanism is not technical inaccuracy; it is wound healing behaviour.

Epithelial thickness mapping using anterior segment OCT confirms that the corneal epithelium actively remodels in response to stromal curvature changes¹ ³. Over time, this can partially negate intended hyperopic correction.

For this reason, hyperopic laser candidates require careful selection and counselling regarding potential need for enhancement.

Primary hyperopic laser surgery is fundamentally different biologically from treating residual hyperopia after lens-based surgery, where central corneal steepening has not been induced.

Understanding epithelial dynamics improves treatment planning and long-term refractive predictability.

References

  1. Reinstein DZ, Archer TJ, Gobbe M. Epithelial thickness profile changes induced by hyperopic LASIK. J Refract Surg. 2009;25(4):388-395.
  2. Shortt AJ, Allan BD, Evans JR. LASIK for hyperopia and hyperopic astigmatism. Cochrane Database Syst Rev. 2013;(5):CD007112.
  3. Li Y, Tan O, Brass R, Weiss JL, Huang D. Corneal epithelial thickness mapping by Fourier-domain OCT. Invest Ophthalmol Vis Sci. 2012;53(7):3435-3441.

Related Topics

About Blue Fin Vision®

Blue Fin Vision® is a GMC-registered, consultant-led ophthalmology clinic with CQC-regulated facilities across London, Hertfordshire, and Essex. Patient outcomes are independently audited by the National Ophthalmology Database, confirming exceptionally low complication rates.